Pfizer’s Paxlovid lowers COVID risks in over 65s

The antiviral treatment developed by Pfizer Inc., Paxlovid, has been determined to reduce both hospitalization and death rates due to COVID-19 in populations older than 65 regardless of their vaccinat…